StockData

Perrigo vs Viatris

PRGO and VTRS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PRGO and VTRS compare

Viatris is the larger company, worth 11 times as much as Perrigo ($23.9B against $2.3B).

Viatris grew revenue faster over the last twelve months (4.3% versus −4.5% for Perrigo).

Both pay dividends: Perrigo yields 5.4% and Viatris 2.3%.

Perrigo scores higher on the StockData Score (10 against 6 for Viatris), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPRGOVTRS
Size and price
Market cap$2.3B$23.9B
Share price$16.24$20.82
Change, 1 year14.7%89.1%
Change, 5 years−60.5%59.2%
Beta (5Y)0.590.86
Employees8,10030K
StockData Score
Total score10 (better)6
Valuation score3 (better)2
Growth score01 (better)
Performance score2 (better)0
Health score11
Dividend score4 (better)2
Valuation
P/S0.6× (better)1.6×
P/B0.9×–
EV/EBITDA–12.6×
P/FCF13.4×11.3× (better)
FCF yield7.5%8.8% (better)
Fair value$22.75$23.22
Margin of safety28.6% (better)10.4%
Growth
Revenue growth (TTM)−4.5%4.3% (better)
Revenue growth, 5Y average0.79%3.7% (better)
Profitability
Gross margin32.3%35.3% (better)
Operating margin−39.4%−0.03% (better)
Net margin−43.3%–
FCF margin4.1%14.3% (better)
Return on equity−51.4%–
Return on invested capital−19.7%–
Financial health
Debt / equity1.35–
Net debt / EBITDA–4.10
Interest coverage–−0.0×
Current ratio2.35 (better)1.55
Altman Z-score−0.431.21 (better)
Piotroski F-score4–
Dividends and buybacks
Dividend yield5.4% (better)2.3%
Years of dividend growth11 (better)0
Dividend growth, 5Y average5.2%–
Buyback yield–1.6%
Shareholder yield5.4% (better)3.9%
Ownership
Held by institutions116%91.5%
Held by insiders0.36%0.36%
Insider net buying, 12 months$0 (better)−$1.1M
Superinvestors holding–3
Short interest, % of float17.8%3.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.